Literature DB >> 21922053

Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Olivier Bensaude1.   

Abstract

This review first discusses ways in which we can evaluate transcription inhibition, describe changes in nuclear structure due to transcription inhibition, and report on genes that are paradoxically stimulated by transcription inhibition. Next, it summarizes the characteristics and mechanisms of commonly used inhibitors: α-amanitin is highly selective for RNAP II and RNAP III but its action is slow, actinomycin D is fast but its selectivity is poor, CDK9 inhibitors such as DRB and flavopiridol are fast and reversible but many genes escape transcription inhibition. New compounds, such as triptolide, are fast and selective and able to completely arrest transcription by triggering rapid degradation of RNAP II.

Entities:  

Year:  2011        PMID: 21922053      PMCID: PMC3173647          DOI: 10.4161/trns.2.3.16172

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  96 in total

1.  A mutation in the largest (catalytic) subunit of RNA polymerase II and its relation to the arrest of the cell cycle in G(1) phase.

Authors:  K Sugaya; S Sasanuma; P R Cook; K Mita
Journal:  Gene       Date:  2001-08-22       Impact factor: 3.688

2.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

Review 3.  Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy.

Authors:  L M Wang; D M Ren
Journal:  Mini Rev Med Chem       Date:  2010-10       Impact factor: 3.862

4.  RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase.

Authors:  Yongwon Jung; Stephen J Lippard
Journal:  J Biol Chem       Date:  2005-11-07       Impact factor: 5.157

5.  Clustered alpha-amanitin resistance mutations in mouse.

Authors:  M S Bartolomei; J L Corden
Journal:  Mol Gen Genet       Date:  1995-03-20

6.  Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target.

Authors:  C M White; O Heidenreich; A Nordheim; T A Beerman
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

7.  Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.

Authors:  Kyle J Christian; Matti A Lang; Françoise Raffalli-Mathieu
Journal:  Mol Pharmacol       Date:  2008-02-22       Impact factor: 4.436

8.  Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin.

Authors:  Gregory J Aune; Kazutaka Takagi; Olivier Sordet; Josée Guirouilh-Barbat; Smitha Antony; Vilhelm A Bohr; Yves Pommier
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

9.  Actinomycin D; renewed RNA synthesis after removal from mammalian cells.

Authors:  A Schluederberg; R C Hendel; S Chavanich
Journal:  Science       Date:  1971-05-07       Impact factor: 47.728

10.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

View more
  245 in total

1.  Co-expressed genes prepositioned in spatial neighborhoods stochastically associate with SC35 speckles and RNA polymerase II factories.

Authors:  Dietmar Rieder; Christian Ploner; Anne M Krogsdam; Gernot Stocker; Maria Fischer; Marcel Scheideler; Christian Dani; Ez-Zoubir Amri; Waltraud G Müller; James G McNally; Zlatko Trajanoski
Journal:  Cell Mol Life Sci       Date:  2013-09-12       Impact factor: 9.261

Review 2.  Translational Control during Cellular Senescence.

Authors:  Matthew J Payea; Carlos Anerillas; Ravi Tharakan; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2021-01-25       Impact factor: 4.272

3.  Total RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis.

Authors:  Sarah A Boswell; Andrew Snavely; Heather M Landry; L Stirling Churchman; Jesse M Gray; Michael Springer
Journal:  Nat Chem Biol       Date:  2017-03-06       Impact factor: 15.040

4.  Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.

Authors:  Piyush Joshi; Tatsuya Seki; Shinobu Kitamura; Andrea Bergano; Bongyong Lee; Ranjan J Perera
Journal:  RNA Biol       Date:  2019-06-16       Impact factor: 4.652

5.  Nuclear speckle fusion via long-range directional motion regulates speckle morphology after transcriptional inhibition.

Authors:  Jiah Kim; Kyu Young Han; Nimish Khanna; Taekjip Ha; Andrew S Belmont
Journal:  J Cell Sci       Date:  2019-04-17       Impact factor: 5.285

6.  Life time of some RNA products of rDNA intergenic spacer in HeLa cells.

Authors:  T Vacík; S Kereïche; I Raška; D Cmarko; E Smirnov
Journal:  Histochem Cell Biol       Date:  2019-07-25       Impact factor: 4.304

7.  Induction of proteotoxic stress by the mycotoxin patulin.

Authors:  Angel Guerra-Moreno; John Hanna
Journal:  Toxicol Lett       Date:  2017-05-18       Impact factor: 4.372

8.  Investigation of RNA Synthesis Using 5-Bromouridine Labelling and Immunoprecipitation.

Authors:  Rikke H Kofoed; Cristine Betzer; Søren Lykke-Andersen; Ewa Molska; Poul H Jensen
Journal:  J Vis Exp       Date:  2018-05-03       Impact factor: 1.355

9.  Stable C0T-1 repeat RNA is abundant and is associated with euchromatic interphase chromosomes.

Authors:  Lisa L Hall; Dawn M Carone; Alvin V Gomez; Heather J Kolpa; Meg Byron; Nitish Mehta; Frank O Fackelmayer; Jeanne B Lawrence
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

10.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.